QUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Moore, KN; Secord, AA; Geller, M; Miller, DS; Cloven, NG; Fleming, GF; Hendrickson, AEW; Azodi, M; DiSilvestro, P; Oza, A; Cristea, M; Berek, JS; Chan, JK; Rimel, BJ; Li, Y; Luptakova, K; Clark, R; Matulonis, UA; Monk, BJ

Published Date

  • October 1, 2018

Published In

Volume / Issue

  • 29 /

Start / End Page

  • 337 - 337

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 43rd ESMO Congress (ESMO)

Conference Location

  • Munich, GERMANY

Conference Start Date

  • October 19, 2018

Conference End Date

  • October 23, 2018